Quick Answer
MDxHealth SA reported R&D Expense of $10.55 million for fiscal year 2024.
MDxHealth SA R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $10.55M | +65.5% |
| 2023 | $6.38M | +16.0% |
| 2022 | $5.50M | -1.6% |
| 2021 | $5.59M | +23.0% |
| 2020 | $4.54M | -49.5% |
| 2019 | $9.00M | — |
- MDxHealth SA showed an increase of +65.5% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2024 period, MDxHealth SA’s r&d expense has grown by 17.3% (from $9.00 million to $10.55 million).
- The most recent figure is from MDxHealth SA’s fiscal year 2024 report (Form 20-F), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: